A bacteriophage is a virus that infects and kills bacteria. The name literally means “bacteria eater,” from the Greek *phagein* (to eat). Phages are the most abundant biological entities on Earth, with an estimated 10³¹ particles across the planet, a number that dwarfs every other organism combined. They exist everywhere bacteria do: soil, oceans, the human gut, sewage, hot springs.
Basic Structure of a Phage
Most bacteriophages share a common body plan, though sizes and shapes vary widely. The core components are a protein shell called a capsid, which houses the genetic material, and in many phages, a tail structure used to attach to and inject DNA into a bacterial cell.
The capsid is built from repeating copies of a major capsid protein arranged in a geometric lattice, typically forming an icosahedral (20-sided) shape. In some of the largest known phages, the capsid can contain over 1,600 individual protein chains along with additional minor proteins that reinforce the structure from the inside, like scaffolding. The genetic material inside can be either DNA or RNA, and either single-stranded or double-stranded depending on the phage. Large phages can carry genomes of over 280,000 base pairs, encoding hundreds of genes.
At the tail end, specialized receptor binding proteins act like molecular keys. These proteins recognize and latch onto very specific molecules on the surface of a target bacterium, whether sugar chains or particular proteins embedded in the cell wall. This lock-and-key recognition is why each phage can only infect a narrow range of bacterial species, sometimes only specific strains within a species.
How Phages Infect Bacteria
Once a phage locks onto its target bacterium, it injects its genetic material through the cell wall and into the bacterial interior. What happens next depends on which of two reproductive strategies the phage follows.
The Lytic Cycle
In the lytic cycle, the phage immediately hijacks the bacterium’s cellular machinery to produce copies of itself. The bacterial cell becomes a phage factory, churning out new viral proteins and assembling new phage particles. When enough copies have been made, the cell bursts open (lyses), releasing dozens to hundreds of new phages that scatter to find fresh bacterial hosts. The original bacterium is destroyed in the process. This entire cycle can complete in as little as 20 to 30 minutes.
The Lysogenic Cycle
Some phages take a quieter approach. Instead of immediately replicating, they integrate their genetic material into the bacterium’s own chromosome, becoming what’s called a prophage. In this state, the viral DNA is copied every time the bacterium divides, silently passing to all daughter cells. The bacterium survives and functions normally, unaware it’s carrying viral instructions in its genome.
This dormancy can last indefinitely, but environmental stress changes the equation. When the bacterium faces starvation, exposure to toxic chemicals, or other harsh conditions, the prophage can activate, cut itself out of the bacterial chromosome, and switch to the lytic cycle, destroying the host cell and releasing a wave of new phages.
Where Phages Are Found
The sheer number of phages on Earth is difficult to grasp. The global population of roughly 10³¹ particles is highly dynamic, turning over every few days as phages infect, replicate, and are cleared. In soil alone, concentrations approach a billion particles per gram. Oceans contain millions per milliliter of seawater.
Your own body hosts a rich community of phages, particularly in the gut, where they form what researchers call the “phageome.” These phages constantly interact with your gut bacteria, shaping which bacterial populations thrive and which get culled. Despite living alongside (and inside) us in staggering numbers, phages pose no direct threat to human cells. They can only infect bacteria because their receptor binding proteins are tuned exclusively to bacterial surface molecules.
Phage Therapy: Using Viruses to Fight Infections
The idea of using phages as medicine is older than antibiotics. Frederick Twort and Félix d’Hérelle independently discovered bacteriophages in 1915 and 1917, and d’Hérelle quickly began experimenting with them as treatments for bacterial infections. Interest faded in the West after penicillin arrived in the 1940s, but phage therapy continued in the Soviet Union and the Republic of Georgia, where dedicated research institutes have used it for decades.
Now, with antibiotic-resistant infections rising globally, phage therapy is drawing serious scientific attention again. The core advantage is specificity. Antibiotics are chemical compounds that kill bacteria broadly, wiping out both harmful and beneficial species. Phages, by contrast, target only the specific bacterial strain they evolved to infect. A lytic phage will destroy its target bacterium while leaving the rest of the microbiome intact. Phages also have a trait no antibiotic can match: they multiply at the site of infection. As long as target bacteria are present, the phage population grows, amplifying the therapeutic dose automatically.
There are practical challenges, though. Because each phage targets such a narrow range of bacteria, clinicians need to identify the exact bacterial strain causing an infection and then find or engineer a phage (or cocktail of phages) that matches it. This personalization makes phage therapy more complex to deliver than a standard antibiotic prescription.
Regulatory Status and Safety
No phage therapy products have received FDA approval for human use in the United States as of 2025. The FDA classifies bacteriophage products as biological products and drugs, regulated through the same investigational pathway used for conventional pharmaceuticals. Patients currently access phage therapy primarily through compassionate use programs or clinical trials.
In Europe, the European Medicines Agency classifies phage therapy as a biological medicinal product, though regulators have acknowledged that existing frameworks don’t fit phage therapy neatly. Individual countries vary in how they implement access, and no phage products have been broadly approved in Europe either.
On the safety side, phages interact with the human immune system in ways researchers are still working to fully understand. Your body can mount immune responses against therapeutic phages, potentially clearing them from the bloodstream before they reach their bacterial targets. Factors like the specific phage used, the route of delivery, and individual patient differences all influence how the immune system reacts. Early clinical experiences suggest phage therapy is generally well tolerated, but the science of predicting and managing immune responses to phages remains in its early stages.
Why Phages Matter Beyond Medicine
Phages play a fundamental ecological role that extends well beyond their potential as medicine. By killing an estimated 20 to 40 percent of ocean bacteria every day, they drive massive nutrient cycling, releasing carbon and other elements back into the environment when bacterial cells burst open. This process influences global carbon cycles and shapes microbial ecosystems from deep-sea vents to topsoil.
In biotechnology, phages serve as precision tools. Scientists use modified phages to deliver genes into bacteria, to display proteins on their surfaces for drug discovery (a technique called phage display), and to detect specific bacterial contaminants in food and water. The food industry already uses approved phage products to control bacteria like Listeria on ready-to-eat foods, one of the few commercial applications that has cleared regulatory hurdles.